The single-step, fast spray-drying process may represent a valuable alterna
tive to the multistep, time-consuming freeze-drying process in the area of
formulation and processing of biopharmaceuticals. In this study, we tested
the use of sucrose and hydroxypropyl-beta-cyclodexlrin (HP-beta-GD) as stab
ilizing excipients in the spray-drying of a model protein, beta-galactosida
se. The solutions were processed using a Buchi 190 cocurrent Mini Spray Dry
er at an outlet temperature of 61 +/- 2 degrees C. The powders were redisso
lved and analyzed for catalytic activity, aggregation, chemical decompositi
on, and thermal susceptibility as observed by high-resolution calorimetry.
Spray-drying significantly inactivated beta-galactosidase. Spray-drying bet
a-galactosidase in the presence of sucrose did not prevent inactivation. Ho
wever, after spray-drying beta-galactosidase in the presence of HP-beta-CD,
or HP-beta-CD and sucrose, full catalytic activity was exhibited on recons
titution. Furthermore, the reconstituted product was unchanged in terms of
molecular weight, charge, and thermal stability. These findings are consist
ent with a hypothesis that the change responsible for inactivation of beta-
galactosidase was mainly a monomolecular, noncovalent change, i.e., the for
mation of incorrect structures, that arose from surface denaturation. This
study clearly demonstrates that cyclodextrins can be useful stabilizing exc
ipients in the preparation of spray-dried protein pharmaceuticals.